CIBC Asset Management Inc Reduces Stock Position in Teleflex Incorporated (NYSE:TFX)

CIBC Asset Management Inc lessened its stake in shares of Teleflex Incorporated (NYSE:TFX) by 3.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,638 shares of the medical technology company’s stock after selling 228 shares during the quarter. CIBC Asset Management Inc’s holdings in Teleflex were worth $1,181,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in TFX. Janus Henderson Group PLC boosted its holdings in shares of Teleflex by 2.8% in the third quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after buying an additional 147,147 shares during the last quarter. FMR LLC boosted its holdings in shares of Teleflex by 70.1% in the third quarter. FMR LLC now owns 269,490 shares of the medical technology company’s stock worth $66,650,000 after buying an additional 111,086 shares during the last quarter. Assenagon Asset Management S.A. boosted its holdings in shares of Teleflex by 457.6% in the third quarter. Assenagon Asset Management S.A. now owns 120,311 shares of the medical technology company’s stock worth $29,755,000 after buying an additional 98,735 shares during the last quarter. Point72 Asset Management L.P. boosted its holdings in shares of Teleflex by 31.2% in the third quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock worth $100,768,000 after buying an additional 96,958 shares during the last quarter. Finally, Parkman Healthcare Partners LLC purchased a new position in shares of Teleflex in the third quarter worth approximately $23,778,000. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Analyst Ratings Changes

TFX has been the topic of a number of research reports. Royal Bank of Canada dropped their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Mizuho decreased their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, November 1st. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Finally, Truist Financial decreased their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, Teleflex currently has a consensus rating of “Moderate Buy” and a consensus target price of $252.50.

Teleflex Trading Up 0.2 %

Teleflex stock opened at $175.43 on Friday. The stock has a market cap of $8.15 billion, a P/E ratio of 34.88, a PEG ratio of 1.73 and a beta of 1.16. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a 1 year low of $165.62 and a 1 year high of $249.90. The firm’s 50 day moving average price is $176.98 and its 200-day moving average price is $207.40.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.